CLINICAL_TRIALS
trial_result
· 2026-04-03
Clinical Trial Update: Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)
Summary
This clinical trial update notes that the prospective clinical assessment study in children with achondroplasia sponsored by QED Therapeutics (BridgeBio) has co…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: QED Therapeutics, a BridgeBio company | Conditions: Achondroplasia | Status: COMPLETED